Lower urinary tract symptoms secondary to benign prostatic hyperplasia: tadalafil

Evidence summary
Reference number: ESNM18
Published: 23 May 2013
Last updated: 14 October 2013

This evidence summary has been updated and replaced by NICE guideline CG97.